Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy.
Laurens P BosmanClaire L Nielsen GerlachJulia Cadrin-TourignyGabriela OrgeronCrystal TichnellBrittney MurrayMimount BourfissJeroen F van der HeijdenSing-Chien YapKatja ZeppenfeldMaarten P van den BergArthur A M WildeFolkert W. AsselbergsHariskrishna TandriHugh Calkinsvan J Peter TintelenCynthia A JamesAnneline S J M Te RielePublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
The ITFC and mITFC provide the highest protection rates, whereas AHA and HRS decrease unnecessary ICD placements. ITFC or mITFC should be used if we consider the 5-year threshold for ICD indication to lie within 5-25% for sustained VA or 2-9% for fast VA. These data will inform decision-making for ICD placement in ARVC.